GLP-1 RA T2D market (~4.5 yrs post-launch)
The FDAs Drug Shortage List is the linchpin of legal GLP-1 compounding
At this low dose level, a standard Ozempic onboarding approach makes sense
Before we can talk about a timeline, we need to be on the same page about what this peptide is and, just as importantly, what it isn't
When semaglutide binds to these receptors, it can alter how your body produces and uses energy, leading to feelings of exhaustion
The bill would require compounding pharmacies that make so-called GLP-1 drugs to use ingredients from FDA approved facilities, list the ingredients and their country of origin on the label, and warn consumers that the compounded drugs are not FDA approved